{"product_id":"harvard-critical-issues-in-tumor-microenvironment-angiogenesis-metastasis-and-immunology-2025","title":"Harvard Critical Issues in Tumor Microenvironment Angiogenesis, Metastasis and Immunology 2025","description":"\u003cdiv class=\"grid-x grid-margin-x\"\u003e\r\n\u003cdiv class=\"cell initial-12 medium-8\"\u003e\r\n\u003cdiv id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnllearningActivityInformation_0\" class=\"pnllearningActivityInformationClass\"\u003e\r\n\u003cdiv id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnlLearningActivityInformationDescription_0\" class=\"pnlLearningActivityInformationDescriptionClass\"\u003e\r\n\u003cdiv id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnllearningActivityInformation_0\" class=\"pnllearningActivityInformationClass\"\u003e\r\n\u003cdiv id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnlLearningActivityInformationDescription_0\" class=\"pnlLearningActivityInformationDescriptionClass\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-371ff86 elementor-widget elementor-widget-heading\" data-id=\"371ff86\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv id=\"product-465185\" class=\"custom-single-product product type-product post-465185 status-publish first instock product_cat-hot-books product_cat-anesthesiology product_cat-cardiology product_cat-hematology product_cat-medical-reference-terminology product_cat-vascular-medicine has-post-thumbnail sale downloadable virtual taxable purchasable product-type-simple\"\u003e\r\n\u003cdiv class=\"afk-single-product-outer \"\u003e\r\n\u003cdiv class=\"akf-p-f-box d-flex f-wrap j-c-b\"\u003e\r\n\u003cdiv class=\"akf-right\"\u003e\r\n\u003cdiv class=\"woo-tab-container custom woo-tc-j\"\u003e\r\n\u003cdiv id=\"descriptionTab\" class=\"tabcontent active\"\u003e\r\n\u003cdiv class=\"prod-desc\"\u003e\r\n\u003cdiv id=\"product-458243\" class=\"custom-single-product product type-product post-458243 status-publish first instock product_cat-cardiology product_cat-pediatrics product_cat-vascular-medicine has-post-thumbnail sale downloadable virtual taxable purchasable product-type-simple\"\u003e\r\n\u003cdiv class=\"afk-single-product-outer \"\u003e\r\n\u003cdiv class=\"akf-p-f-box d-flex f-wrap j-c-b\"\u003e\r\n\u003cdiv class=\"akf-right\"\u003e\r\n\u003cdiv class=\"woo-tab-container custom woo-tc-j\"\u003e\r\n\u003cdiv id=\"descriptionTab\" class=\"tabcontent active\"\u003e\r\n\u003cdiv class=\"prod-desc\"\u003e\r\n\u003cdiv id=\"bylineInfo\" class=\"a-section a-spacing-micro bylineHidden feature\"\u003e\r\n\u003cdiv id=\"bylineInfo\" class=\"a-section a-spacing-micro bylineHidden feature\"\u003e\r\n\u003cdiv id=\"bylineInfo\" class=\"a-section a-spacing-micro bylineHidden feature\"\u003e\r\n\u003cdiv id=\"bylineInfo\" class=\"a-section a-spacing-micro bylineHidden feature\"\u003e\r\n\u003ch3\u003eHarvard Critical Issues in Tumor Microenvironment Angiogenesis, Metastasis and Immunology 2025\u003c\/h3\u003e\r\n\u003cstrong\u003eInclude: 20 videos + 20 sub file vtt + 14 pdfs, size: 21.26 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eTarget Audience: oncologists, cancer researchers, immunologists\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eInformation:\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eCritical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology \u003cem\u003e40th Annual Offering \u003c\/em\u003eNovember 10 – 14, 2025\u003c\/strong\u003e\r\n\r\nThe “40th Annual Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology” course, directed by Professor Rakesh K. Jain, will continue to offer the best in critical analysis of what is currently known about the tumor microenvironment, including lectures covering: angiogenesis, metastasis, immunology, metabolism, microbiome, chronobiology, carcinoma-associated fibroblasts, cancer-neuroscience, adoptive cell therapies including chimeric antigen receptor (CAR) T-cells, and integrating physical sciences and AI in oncology. The faculty is internationally recognized. They will present the latest findings from their laboratories and clinics. The goal of this course is to highlight key gaps in present knowledge of cancer and outline future directions for research at the bench and in the clinic.\r\n\r\nThe course will return to a four-day in-person format. Learning formats will include didactic lectures, trainee-led Q\u0026amp;A and group discussions. The faculty will encourage an open discussion and will provide critical comments on challenges and future opportunities in research in cancer and in the establishment of novel therapeutic approaches and biomarkers to guide treatment. The aim of this course is to analyze and synthesize the most up-to-date findings. Our faculty will present valuable information in a systematic and comprehensive framework, along with a critical review of various measurement techniques. This course is dedicated to helping to improve clinical translation of this knowledge and competence, leading to improved cancer treatment.\r\n\r\nTo celebrate the 40\u003csup\u003eth\u003c\/sup\u003e anniversary, we have added a 5\u003csup\u003eth\u003c\/sup\u003e Trainee-focused day to our course where the course participants will have the opportunity to present a scientific poster during a poster symposium, along with attend a roundtable discussion session on career guidance for  biomedical scientists and engineers.\r\n\u003ch4\u003eLEARNING OBJECTIVES:\u003c\/h4\u003e\r\n\u003cem\u003eUpon completion of our Critical Issues in Tumor Microenvironment course, participants will be able to:\u003c\/em\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eIdentify pharmacological approaches to normalize the tumor microenvironment, including tumor-associated blood vessels, fibroblasts and the extracellular matrix\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate molecularly targeted agents approved or currently in clinical development in combination with immunotherapies for cancer treatment and incorporate them into practice.\u003c\/li\u003e\r\n \t\u003cli\u003eAssess relevant, state-of-the-art, or translational pre-clinical models of anti-cancer therapies for adult and pediatric malignancies.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize the steps and determinants of the metastatic process of cancer.\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify emerging determinants of immunotherapy outcomes, including blood vessels, fibroblasts, extracellular matrix, neuronal-tumor interactions, circadian cycle, microbiome, and discuss potential approaches to harness them.\u003c\/li\u003e\r\n \t\u003cli\u003eCompare correlative studies of biomarkers and their response and resistance to immunotherapies in cancer patients.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate state-of-the-art genetic and imaging techniques and their applications in pre-clinical and clinical studies.\u003c\/li\u003e\r\n \t\u003cli\u003eUnderstand the applications of AI in cancer care and research\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003eWho Should Attend This Course?\u003c\/h4\u003e\r\nThe course is directed at physicians and researchers.\r\n\r\nThe \u003cem\u003eHarvard Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology 2025\u003c\/em\u003e course is best for oncologists, cancer researchers, immunologists, translational scientists, and advanced trainees who want cutting‑edge, multidisciplinary insights into tumor biology, angiogenesis, metastasis, immunology, and emerging therapies.\r\n\u003ch3\u003e👩‍⚕️ Who Should Attend\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eMedical oncologists and hematologists seeking deeper understanding of tumor biology to guide clinical practice.\u003c\/li\u003e\r\n \t\u003cli\u003eCancer researchers and translational scientists working on angiogenesis, metastasis, immunotherapy, and tumor microenvironment.\u003c\/li\u003e\r\n \t\u003cli\u003eImmunologists and molecular biologists studying immune regulation and cancer immunotherapy.\u003c\/li\u003e\r\n \t\u003cli\u003eRadiation and surgical oncologists interested in how microenvironmental factors influence treatment outcomes.\u003c\/li\u003e\r\n \t\u003cli\u003ePharmaceutical and biotech professionals developing anti‑cancer drugs, biologics, and cell therapies.\u003c\/li\u003e\r\n \t\u003cli\u003eGraduate students, postdocs, and fellows in oncology, immunology, or biomedical sciences preparing for academic or industry careers.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e📚 What You’ll Learn\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eTumor microenvironment fundamentals: angiogenesis, metastasis, immunology, metabolism, microbiome, and chronobiology.\u003c\/li\u003e\r\n \t\u003cli\u003eEmerging therapeutic strategies: adoptive cell therapies (CAR‑T, TCR), checkpoint inhibitors, and novel biologics.\u003c\/li\u003e\r\n \t\u003cli\u003eCancer neuroscience and fibroblast biology: how stromal and neural interactions drive tumor progression.\u003c\/li\u003e\r\n \t\u003cli\u003eIntegration of physical sciences and AI in oncology: innovative approaches to modeling and predicting tumor behavior.\u003c\/li\u003e\r\n \t\u003cli\u003eClinical translation: bridging laboratory discoveries with patient care to improve cancer treatment outcomes.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n \r\n\r\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\r\n\u003ch4\u003eMonday, November 10, 2025\u003c\/h4\u003e\r\n\u003ctable\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e9:00 A.M\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eCheck-in\/Registration, Continental Breakfast\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e10:00 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eOpening Remarks\u003c\/strong\u003e\u003c\/b\u003e Rakesh K. Jain\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e10:10 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eTumor Microenvironment I: Angiogenesis and Vascular Function\u003c\/strong\u003e\u003c\/b\u003e Rakesh K. Jain\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:20 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:35 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eBreak\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:50 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eTumor Microenvironment II: Vascular Normalization and Immunotherapy \u003c\/strong\u003e\u003c\/b\u003e Rakesh K. Jain\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e1:10  P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e1:25 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eLunch Break – Boxed lunches provided\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e2:25 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eTumor Microenvironment III: Extracellular Matrix, Lymphatics and Metastasis\u003c\/strong\u003e\u003c\/b\u003e Rakesh K. Jain\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e3:45 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e4:00 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eBreak\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e4:30 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eCancer Immunology and Immunotherapy Overview\u003c\/strong\u003e\u003c\/b\u003e Arlene Sharpe\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e5:35 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e5:50 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eAdjourn\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003ch4\u003eTuesday, November 11, 2025\u003c\/h4\u003e\r\n\u003ctable\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e9:00 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eContinental Breakfast\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e10:00 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eCircadian Clock  and Metabolic Vulnerabilities of Cancer\u003c\/strong\u003e\u003c\/b\u003e\u003cb\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003c\/b\u003eChi Van Dang\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:05 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:20 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eBreak\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:50 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eSkull Bone Marrow as a Site for Immuno-Surveillance of Healthy Brain and Brain Tumors \u003c\/strong\u003e\u003c\/b\u003eJonathan Kipnis\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e12:55 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e1:10 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eLunch Break – on your own\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e2:10 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eDeterminants of How Tumors Use Metabolism to Support Growth \u003c\/strong\u003e\u003c\/b\u003eMatthew Vander Heiden\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e3:15 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e3:30 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eBreak\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e4:00 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eUsing Cell Transfer to Remodel the Tumor Microenvrionment\u003c\/strong\u003e\u003c\/b\u003e Carl June\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e5:05 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e5:20 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eAdjourn\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003ch4\u003eWednesday, November 12, 2025\u003c\/h4\u003e\r\n\u003ctable\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e9:00 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eContinental Breakfast\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e10:00 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eAI in Basic and Clinical Oncology\u003c\/strong\u003e\u003c\/b\u003e Eliezer Van Allen\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:05 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:20 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eBreak\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:50 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eMicrobiota: a Key Orchestrator of Cancer Therapy \u003c\/strong\u003e\u003c\/b\u003eGiorgio Trinchieri\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e12:55 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e1:10  P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eLunch Break – on your own\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e2:10 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eIdentifying Immune Vulnerabilities in Solid Tumors \u003c\/strong\u003e\u003c\/b\u003eLisa Coussens\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e3:15 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e3:30 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eBreak\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e4:00 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eRREBELLIOUS INTERFERENCE: Challenging old paradigms and discovering new strategies for targeting pediatric brain tumors \u003c\/strong\u003e\u003c\/b\u003eRobert Wechsler-Reya\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e5:05 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e5:20 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eAdjourn\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003ch4\u003eThursday, November 13, 2025\u003c\/h4\u003e\r\n\u003ctable\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e9:00 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eContinental Breakfast\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e10:00 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eDissecting the Ecosystem of Gliomas by Single-Cell and Spatial Genomics \u003c\/strong\u003e\u003c\/b\u003eMario Suva\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:05 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:20 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eBreak\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:50 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eMechanisms of Malignant Progression \u003c\/strong\u003e\u003c\/b\u003eRobert Weinberg\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e12:55 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e1:10  P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eLunch Break – on your own\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e2:10 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eFibroblast Heterogeneity in Solid Tumors: Implications for Pancreatic Cancer \u003c\/strong\u003e\u003c\/b\u003eDavid Tuveson\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e3:15 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e3:30 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eBreak\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e4:00 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eNeural Influences on Primary and Metastatic Brain Tumors\u003c\/strong\u003e\u003c\/b\u003e Frank Winkler\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e5:05 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e5:20 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eSummary and closing remarks\u003c\/strong\u003e\u003c\/b\u003e Rakesh K. Jain\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003ch4\u003eFriday , November 14th, 2025\u003c\/h4\u003e\r\n\u003ctable width=\"1186\"\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003ctd width=\"161\"\u003e\u003cb\u003e\u003cstrong\u003e9:00  A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003ePoster set up\/ \u003cb\u003e\u003cstrong\u003eContinental Breakfast\u003c\/strong\u003e\u003c\/b\u003e\n\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e10:00 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eLessons\u003c\/strong\u003e\u003c\/b\u003e \u003cb\u003e\u003cstrong\u003efrom the Clinic: Novel Diagnostics and Therapeutic Outcomes \u003c\/strong\u003e\u003c\/b\u003eGeorge Sledge\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:20 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eBreak\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e11:50 A.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eEmerging strategies to improve CAR-T cell therapy for glioblastoma and other solid tumors \u003c\/strong\u003e\u003c\/b\u003eHideho Okada\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e1:10 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cem\u003eLunch Break – Boxed lunches will be provided\u003c\/em\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e2:10 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003ePoster Session\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e3:10 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003ePoster Award Presentation\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e3:30 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cb\u003e\u003cstrong\u003eCareer Round Table Discussion\u003c\/strong\u003e\u003c\/b\u003e\r\n\r\nAcademia: Frank Winkler, MD, PhD |Eva Sevick-Muraca, PhD | Melody Swartz, PhD\r\n\r\nIndustry: George Sledge, MD | Zohreh Amoozgar, PhD\r\n\r\nLaw Firm: Carla Mouta-Bellum, PhD, JD\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003e5:00 P.M.\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003cb\u003e\u003cstrong\u003eNetworking Reception\u003c\/strong\u003e\u003c\/b\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954528653410,"sku":"MED-AMB05396","price":100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Harvard-Critical-Issues-in-Tumor-Microenvironment-Angiogenesis-Metastasis-and-Immunology-2025_a9f67751-a695-4210-baee-dc6acebaef99.jpg?v=1779378997","url":"https:\/\/meducourse.com\/products\/harvard-critical-issues-in-tumor-microenvironment-angiogenesis-metastasis-and-immunology-2025","provider":"Meducourse","version":"1.0","type":"link"}